Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 39.41%. However, over the last six months, the performance has been weaker by 107.72%. The price of NPCE increased 46.20% over the last 30 days. And in the last five days, it has surged by 28.71%.
NeuroPace Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $15.11 on 05/14/25, while the lowest price for the same period was registered at $5.45 on 10/25/24.
52-week price history of NPCE Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. NeuroPace Inc’s current trading price is 3.24% away from its 52-week high, while its distance from the 52-week low is 186.24%. The stock’s price range during this period has varied between$5.45 and $15.11. The NeuroPace Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.81 million for the day, a figure considerably higher than their average daily volume of 0.24 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
NeuroPace Inc (NPCE) has experienced a quarterly rise of 29.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 510.95M and boasts a workforce of 184 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.18, with a change in price of +4.08. Similarly, NeuroPace Inc recorded 204,896 in trading volume during the last 100 days, posting a change of +35.42%.
NPCE’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NPCE stands at 3.01. Similarly, the long-term debt-to-equity ratio is also 2.93.
NPCE Stock Stochastic Average
As of today, NeuroPace Inc’s raw stochastic average for the last 50 days stands at 88.87%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 88.06%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 88.65% and 90.00%, respectively.
